Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

External Link

2013

Psychiatry

Philip J. Candilis

Articles 1 - 1 of 1

Full-Text Articles in Medicine and Health Sciences

A Double-Blind Randomized Controlled Trial Of Olanzapine Plus Sertraline Vs Olanzapine Plus Placebo For Psychotic Depression: The Study Of Pharmacotherapy Of Psychotic Depression (Stop-Pd), Barnett Meyers, Alastair Flint, Anthony Rothschild, Benoit Mulsant, Ellen Whyte, Catherine Peasley-Miklus, Eros Papademetriou, Andrew Leon, Moonseong Heo, Paul Appelbaum, Philip Candilis, Nancy Byatt, Kristina Deligiannidis Nov 2013

A Double-Blind Randomized Controlled Trial Of Olanzapine Plus Sertraline Vs Olanzapine Plus Placebo For Psychotic Depression: The Study Of Pharmacotherapy Of Psychotic Depression (Stop-Pd), Barnett Meyers, Alastair Flint, Anthony Rothschild, Benoit Mulsant, Ellen Whyte, Catherine Peasley-Miklus, Eros Papademetriou, Andrew Leon, Moonseong Heo, Paul Appelbaum, Philip Candilis, Nancy Byatt, Kristina Deligiannidis

Philip J. Candilis

CONTEXT: Evidence for the efficacy of combination pharmacotherapy has been limited and without positive trials in geriatric patients with major depression (MD) with psychotic features. OBJECTIVES: To compare remission rates of MD with psychotic features in those treated with a combination of atypical antipsychotic medication plus a serotonin reuptake inhibitor with those treated with antipsychotic monotherapy; and to compare response by age. DESIGN: Twelve-week, double-blind, randomized, controlled trial. SETTING: Clinical services of 4 academic sites. Patients Two hundred fifty-nine subjects with MD with psychotic features randomized by age ( or =60 years) (mean [standard deviation (SD)], 41.3 [10.8] years in …